series-c-plus
Stage
2018
Founded
2
Investors
About
OncoHost develops the PROphet platform, a blood-based proteomic test using AI and bioinformatic pattern recognition to generate a personalized score predicting patient benefit from PD-1/PD-L1 inhibitor therapies for oncology treatment decisions.
Explore OncoHost's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.